This article is more than 5 years old. Information may no longer be current.

WaveLight AG plans to sell off its intraocular surgery business unit

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ERLANGEN, Germany — WaveLight AG intends to dispose of its intraocular surgery business unit, the company announced in a press release.

As part of the disposal of the intraocular surgery business unit resolved by WaveLight AG's executive committee on Dec. 6, WaveLight intends to sell the wholly owned subsidiary WaveLight GmbH and to divest its 30% equity interest in the Dutch company MDP (Medical Device Production) B.V.

Details of the planned disposal of the holdings in the intraocular surgery business unit are currently being negotiated.

WaveLight expects the sale of the equity interests to result in expenses of up to Euro 5 million. The transaction is subject to approval by WaveLight AG's supervisory board, according to the release.

WaveLight had acquired the Berlin-based distribution company Acrimed GmbH, which is now WaveLight GmbH, and its equity interest in MDP B.V. in September 2005 as part of an expansion of its ophthalmological expertise, the release said.